Point of Care Diagnostic Market - Forecasts from 2019 to 2024
The global Point of Care Diagnostics market was valued at US$17.238 billion in 2018 and is expected to grow at a CAGR of 3.02% over the forecast period to reach a total market size of US$20.603 billion by 2024. Point of Care (POC) Diagnostic or Near-Patient Testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. The results of Point of Care diagnostic devices have helped in rapid treatment to the patients; empowering clinicians to make decisions and addressing challenges of health disparities. Its market has been on a steady growth owing to the factors such as the high prevalence of infectious diseases in developing countries, increasing incidences of target diseases, rising preference of home healthcare across the globe, and growing government initiatives supporting the adoption of POC diagnostic products. Moreover, improvement in lab automation techniques coupled with the introduction of cost-effective and high-quality medical solutions and its use by the minimally skilled professionals for diagnostics also serves as the reason to drive the growth in the market.
However, the development of personalized tests linked to a drug has a high risk as the product might not make it to the market because of the restrictions and regulations on various drugs throughout the world. The POC diagnostic devices have helped the disadvantaged and under-served population globally due to its low cost. The investment in research and innovation by the key players is expected to grow the market at a steady pace.
The “Point of Care Diagnostic Market – Forecasts from 2019 to 2024” is an exhaustive study of this niche technology market that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by testing, platform, mode, end-user, and geography.
The point of care diagnostic market has been segmented based on testing, platform, mode, end-user, and geography. Based on testing the market has been segmented into Cardio-Metabolic Monitoring Kits, Infectious Disease Testing Kits, Glucose Monitoring Kits, Coagulation Monitoring Kits, Pregnancy, and Fertility Testing Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Hematology Testing Kits, and others. By platform, the market has been classified into Lateral Flow Assay, Dipsticks, Microfluidics, Molecular Diagnostics, and Others. By mode, the market is classified as Prescription and OTC. By end-user, the market is classified as Diagnostic Center, Research Laboratories, Homecare Setting, and Others.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the point of care diagnostic market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the point of care diagnostic market.
Segmentation:
By Testing
Cardio-Metabolic Monitoring Kits
Infectious Disease Testing Kits
Glucose Monitoring Kits
Coagulation Monitoring Kits
Pregnancy and Fertility Testing Kits
Tumor/Cancer Markers
Urinalysis Testing Kits
Hematology Testing Kits
Others
By Platform
Lateral Flow Assay
Dipsticks
Micro Fluidics
Molecular Diagnostics
Others
By end-user
Diagnostic Centers
Research Laboratories
Home Care Settings
Others
By Geography
North America
USA
Mexico
Canada
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Israel
Saudi Arabia
Others
Asia Pacific
China
Japan
South Korea
India
Others
However, the development of personalized tests linked to a drug has a high risk as the product might not make it to the market because of the restrictions and regulations on various drugs throughout the world. The POC diagnostic devices have helped the disadvantaged and under-served population globally due to its low cost. The investment in research and innovation by the key players is expected to grow the market at a steady pace.
The “Point of Care Diagnostic Market – Forecasts from 2019 to 2024” is an exhaustive study of this niche technology market that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by testing, platform, mode, end-user, and geography.
The point of care diagnostic market has been segmented based on testing, platform, mode, end-user, and geography. Based on testing the market has been segmented into Cardio-Metabolic Monitoring Kits, Infectious Disease Testing Kits, Glucose Monitoring Kits, Coagulation Monitoring Kits, Pregnancy, and Fertility Testing Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Hematology Testing Kits, and others. By platform, the market has been classified into Lateral Flow Assay, Dipsticks, Microfluidics, Molecular Diagnostics, and Others. By mode, the market is classified as Prescription and OTC. By end-user, the market is classified as Diagnostic Center, Research Laboratories, Homecare Setting, and Others.
Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and the Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the point of care diagnostic market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the point of care diagnostic market.
Segmentation:
By Testing
Cardio-Metabolic Monitoring Kits
Infectious Disease Testing Kits
Glucose Monitoring Kits
Coagulation Monitoring Kits
Pregnancy and Fertility Testing Kits
Tumor/Cancer Markers
Urinalysis Testing Kits
Hematology Testing Kits
Others
By Platform
Lateral Flow Assay
Dipsticks
Micro Fluidics
Molecular Diagnostics
Others
By end-user
Diagnostic Centers
Research Laboratories
Home Care Settings
Others
By Geography
North America
USA
Mexico
Canada
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Israel
Saudi Arabia
Others
Asia Pacific
China
Japan
South Korea
India
Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope Of The Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power Of Suppliers
4.5.2. Bargaining Power Of Buyers
4.5.3. Threat Of New Entrants
4.5.4. Threat Of Substitutes
4.5.5. Competitive Rivalry In The Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. POINT OF CARE DIAGNOSTIC MARKET BY TESTING
5.1. Cardio-Metabolic Monitoring Kits
5.2. Infectious Disease Testing Kits
5.3. Glucose Monitoring Kits
5.4. Coagulation Monitoring Kits
5.5. Pregnancy And Fertility Testing Kits
5.6. Tumor/Cancer Markers
5.7. Urinalysis Testing Kits
5.8. Hematology Testing Kits
5.9. Others
6. POINT OF CARE DIAGNOSTIC MARKET BY PLATFORM
6.1. Lateral Flow Assay
6.2. Dipsticks
6.3. Micro Fluidics
6.4. Molecular Diagnostics
6.5. Others
7. POINT OF CARE DIAGNOSTIC MARKET BY MODE
7.1. Prescription
7.2. OTC
8. POINT OF CARE DIAGNOSTIC MARKET BY END-USER
8.1. Diagnostic Centers
8.2. Research Laboratories
8.3. Home Care Settings
8.4. Others
9. POINT OF CARE MARKET BY GEOGRAPHY
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Spain
9.3.5. Others
9.4. Middle East And Africa
9.4.1. Israel
9.4.2. Saudi Arabia
9.4.3. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. South Korea
9.5.4. India
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1. Market Positioning Matrix and Ranking
10.2. Strategies Of Key Players
10.3. Recent Investments And Deals
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.2. Becton, Dickinson and Company
11.3. Chembio Diagnostic Systems
11.4. Danaher Corporation
11.5. EKF Diagnostics
11.6. Nova Biomedical
11.7. Quidel Corporation
11.8. Siemens AG
11.9. Trinity Biotech
11.10. Werfenlife S.A
List Of Figures
List Of Tables
1.1. Market Overview
1.2. Market Definition
1.3. Scope Of The Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power Of Suppliers
4.5.2. Bargaining Power Of Buyers
4.5.3. Threat Of New Entrants
4.5.4. Threat Of Substitutes
4.5.5. Competitive Rivalry In The Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. POINT OF CARE DIAGNOSTIC MARKET BY TESTING
5.1. Cardio-Metabolic Monitoring Kits
5.2. Infectious Disease Testing Kits
5.3. Glucose Monitoring Kits
5.4. Coagulation Monitoring Kits
5.5. Pregnancy And Fertility Testing Kits
5.6. Tumor/Cancer Markers
5.7. Urinalysis Testing Kits
5.8. Hematology Testing Kits
5.9. Others
6. POINT OF CARE DIAGNOSTIC MARKET BY PLATFORM
6.1. Lateral Flow Assay
6.2. Dipsticks
6.3. Micro Fluidics
6.4. Molecular Diagnostics
6.5. Others
7. POINT OF CARE DIAGNOSTIC MARKET BY MODE
7.1. Prescription
7.2. OTC
8. POINT OF CARE DIAGNOSTIC MARKET BY END-USER
8.1. Diagnostic Centers
8.2. Research Laboratories
8.3. Home Care Settings
8.4. Others
9. POINT OF CARE MARKET BY GEOGRAPHY
9.1. North America
9.1.1. USA
9.1.2. Canada
9.1.3. Mexico
9.2. South America
9.2.1. Brazil
9.2.2. Argentina
9.2.3. Others
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. United Kingdom
9.3.4. Spain
9.3.5. Others
9.4. Middle East And Africa
9.4.1. Israel
9.4.2. Saudi Arabia
9.4.3. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. South Korea
9.5.4. India
9.5.5. Others
10. COMPETITIVE INTELLIGENCE
10.1. Market Positioning Matrix and Ranking
10.2. Strategies Of Key Players
10.3. Recent Investments And Deals
11. COMPANY PROFILES
11.1. Abbott Laboratories
11.2. Becton, Dickinson and Company
11.3. Chembio Diagnostic Systems
11.4. Danaher Corporation
11.5. EKF Diagnostics
11.6. Nova Biomedical
11.7. Quidel Corporation
11.8. Siemens AG
11.9. Trinity Biotech
11.10. Werfenlife S.A
List Of Figures
List Of Tables
